Global Nivolumab Injection Market Research Report 2023

Nivolumab Injection Market

Nivolumab Injection is suitable for treating adult patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) who are negative for mutations in the epidermal growth factor receptor (EGFR) gene and negative for anaplastic lymphoma kinase (ALK), who have previously undergone platinum-containing chemotherapy and whose disease has progressed or is intolerable.

The global Nivolumab Injection market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

North American market for Nivolumab Injection is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Nivolumab Injection is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global manufacturers of Nivolumab Injection include AbbVie, Allergan, Ono Pharmaceutical, Sinopharm and Bristol-Myers Squibb, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Nivolumab Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Nivolumab Injection.

The Nivolumab Injection market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Nivolumab Injection market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Nivolumab Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

Scope of Nivolumab Injection Market Report

Core Chapters

1.1 Product Overview and Scope of Nivolumab Injection

1.2 Nivolumab Injection Segment by Type

1.2.1 Global Nivolumab Injection Market Value Comparison by Type (2023-2029)

1.2.2 100IU

1.2.3 50IU

1.2.4 Other

1.3 Nivolumab Injection Segment by Application

1.3.1 Global Nivolumab Injection Market Value by Application: (2023-2029)

1.3.2 Unresectable Melanoma

1.3.3 Metastatic Melanoma

1.3.4 Metastatic Squamous NSCLC

1.3.5 Classical Hodgkin Lymphoma

1.3.6 Renal Cell Carcinoma

1.3.7 Other

1.4 Global Nivolumab Injection Market Size Estimates and Forecasts

1.4.1 Global Nivolumab Injection Revenue 2018-2029

1.4.2 Global Nivolumab Injection Sales 2018-2029

1.4.3 Global Nivolumab Injection Market Average Price (2018-2029)

1.5 Assumptions and Limitations

2.1 Global Nivolumab Injection Sales Market Share by Manufacturers (2018-2023)

2.2 Global Nivolumab Injection Revenue Market Share by Manufacturers (2018-2023)

2.3 Global Nivolumab Injection Average Price by Manufacturers (2018-2023)

2.4 Global Nivolumab Injection Industry Ranking 2021 VS 2022 VS 2023

2.5 Global Key Manufacturers of Nivolumab Injection, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Nivolumab Injection, Product Type & Application

2.7 Nivolumab Injection Market Competitive Situation and Trends

2.7.1 Nivolumab Injection Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Nivolumab Injection Players Market Share by Revenue

2.7.3 Global Nivolumab Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3.1 Global Nivolumab Injection Market Size by Region: 2018 Versus 2022 Versus 2029

3.2 Global Nivolumab Injection Global Nivolumab Injection Sales by Region: 2018-2029

3.2.1 Global Nivolumab Injection Sales by Region: 2018-2023

3.2.2 Global Nivolumab Injection Sales by Region: 2024-2029

3.3 Global Nivolumab Injection Global Nivolumab Injection Revenue by Region: 2018-2029

3.3.1 Global Nivolumab Injection Revenue by Region: 2018-2023

3.3.2 Global Nivolumab Injection Revenue by Region: 2024-2029

3.4 North America Nivolumab Injection Market Facts & Figures by Country

3.4.1 North America Nivolumab Injection Market Size by Country: 2018 VS 2022 VS 2029

3.4.2 North America Nivolumab Injection Sales by Country (2018-2029)

3.4.3 North America Nivolumab Injection Revenue by Country (2018-2029)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Nivolumab Injection Market Facts & Figures by Country

3.5.1 Europe Nivolumab Injection Market Size by Country: 2018 VS 2022 VS 2029

3.5.2 Europe Nivolumab Injection Sales by Country (2018-2029)

3.5.3 Europe Nivolumab Injection Revenue by Country (2018-2029)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Nivolumab Injection Market Facts & Figures by Country

3.6.1 Asia Pacific Nivolumab Injection Market Size by Country: 2018 VS 2022 VS 2029

3.6.2 Asia Pacific Nivolumab Injection Sales by Country (2018-2029)

3.6.3 Asia Pacific Nivolumab Injection Revenue by Country (2018-2029)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Nivolumab Injection Market Facts & Figures by Country

3.7.1 Latin America Nivolumab Injection Market Size by Country: 2018 VS 2022 VS 2029

3.7.2 Latin America Nivolumab Injection Sales by Country (2018-2029)

3.7.3 Latin America Nivolumab Injection Revenue by Country (2018-2029)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Nivolumab Injection Market Facts & Figures by Country

3.8.1 Middle East and Africa Nivolumab Injection Market Size by Country: 2018 VS 2022 VS 2029

3.8.2 Middle East and Africa Nivolumab Injection Sales by Country (2018-2029)

3.8.3 Middle East and Africa Nivolumab Injection Revenue by Country (2018-2029)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4.1 Global Nivolumab Injection Sales by Type (2018-2029)

4.1.1 Global Nivolumab Injection Sales by Type (2018-2023)

4.1.2 Global Nivolumab Injection Sales by Type (2024-2029)

4.1.3 Global Nivolumab Injection Sales Market Share by Type (2018-2029)

4.2 Global Nivolumab Injection Revenue by Type (2018-2029)

4.2.1 Global Nivolumab Injection Revenue by Type (2018-2023)

4.2.2 Global Nivolumab Injection Revenue by Type (2024-2029)

4.2.3 Global Nivolumab Injection Revenue Market Share by Type (2018-2029)

4.3 Global Nivolumab Injection Price by Type (2018-2029)

5.1 Global Nivolumab Injection Sales by Application (2018-2029)

5.1.1 Global Nivolumab Injection Sales by Application (2018-2023)

5.1.2 Global Nivolumab Injection Sales by Application (2024-2029)

5.1.3 Global Nivolumab Injection Sales Market Share by Application (2018-2029)

5.2 Global Nivolumab Injection Revenue by Application (2018-2029)

5.2.1 Global Nivolumab Injection Revenue by Application (2018-2023)

5.2.2 Global Nivolumab Injection Revenue by Application (2024-2029)

5.2.3 Global Nivolumab Injection Revenue Market Share by Application (2018-2029)

5.3 Global Nivolumab Injection Price by Application (2018-2029)

6.1 AbbVie

6.1.1 AbbVie Corporation Information

6.1.2 AbbVie Description and Business Overview

6.1.3 AbbVie Nivolumab Injection Sales, Revenue and Gross Margin (2018-2023)

6.1.4 AbbVie Nivolumab Injection Product Portfolio

6.1.5 AbbVie Recent Developments/Updates

6.2 Allergan

6.2.1 Allergan Corporation Information

6.2.2 Allergan Description and Business Overview

6.2.3 Allergan Nivolumab Injection Sales, Revenue and Gross Margin (2018-2023)

6.2.4 Allergan Nivolumab Injection Product Portfolio

6.2.5 Allergan Recent Developments/Updates

6.3 Ono Pharmaceutical

6.3.1 Ono Pharmaceutical Corporation Information

6.3.2 Ono Pharmaceutical Description and Business Overview

6.3.3 Ono Pharmaceutical Nivolumab Injection Sales, Revenue and Gross Margin (2018-2023)

6.3.4 Ono Pharmaceutical Nivolumab Injection Product Portfolio

6.3.5 Ono Pharmaceutical Recent Developments/Updates

6.4 Sinopharm

6.4.1 Sinopharm Corporation Information

6.4.2 Sinopharm Description and Business Overview

6.4.3 Sinopharm Nivolumab Injection Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Sinopharm Nivolumab Injection Product Portfolio

6.4.5 Sinopharm Recent Developments/Updates

6.5 Bristol-Myers Squibb

6.5.1 Bristol-Myers Squibb Corporation Information

6.5.2 Bristol-Myers Squibb Description and Business Overview

6.5.3 Bristol-Myers Squibb Nivolumab Injection Sales, Revenue and Gross Margin (2018-2023)

6.5.4 Bristol-Myers Squibb Nivolumab Injection Product Portfolio

6.5.5 Bristol-Myers Squibb Recent Developments/Updates

7.1 Nivolumab Injection Industry Chain Analysis

7.2 Nivolumab Injection Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Nivolumab Injection Production Mode & Process

7.4 Nivolumab Injection Sales and Marketing

7.4.1 Nivolumab Injection Sales Channels

7.4.2 Nivolumab Injection Distributors

7.5 Nivolumab Injection Customers

8.1 Nivolumab Injection Industry Trends

8.2 Nivolumab Injection Market Drivers

8.3 Nivolumab Injection Market Challenges

8.4 Nivolumab Injection Market Restraints

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

List of Tables

    Table 1. Global Nivolumab Injection Market Value Comparison by Type (2023-2029) & (US$ Million)

    Table 2. Global Nivolumab Injection Market Value Comparison by Application (2023-2029) & (US$ Million)

    Table 3. Global Nivolumab Injection Market Competitive Situation by Manufacturers in 2022

    Table 4. Global Nivolumab Injection Sales (K Units) of Key Manufacturers (2018-2023)

    Table 5. Global Nivolumab Injection Sales Market Share by Manufacturers (2018-2023)

    Table 6. Global Nivolumab Injection Revenue (US$ Million) by Manufacturers (2018-2023)

    Table 7. Global Nivolumab Injection Revenue Share by Manufacturers (2018-2023)

    Table 8. Global Market Nivolumab Injection Average Price (US$/Unit) of Key Manufacturers (2018-2023)

    Table 9. Global Key Players of Nivolumab Injection, Industry Ranking, 2021 VS 2022 VS 2023

    Table 10. Global Key Manufacturers of Nivolumab Injection, Manufacturing Sites & Headquarters

    Table 11. Global Key Manufacturers of Nivolumab Injection, Product Type & Application

    Table 12. Global Key Manufacturers of Nivolumab Injection, Date of Enter into This Industry

    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

    Table 14. Global Nivolumab Injection by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nivolumab Injection as of 2022)

    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

    Table 16. Global Nivolumab Injection Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 17. Global Nivolumab Injection Sales by Region (2018-2023) & (K Units)

    Table 18. Global Nivolumab Injection Sales Market Share by Region (2018-2023)

    Table 19. Global Nivolumab Injection Sales by Region (2024-2029) & (K Units)

    Table 20. Global Nivolumab Injection Sales Market Share by Region (2024-2029)

    Table 21. Global Nivolumab Injection Revenue by Region (2018-2023) & (US$ Million)

    Table 22. Global Nivolumab Injection Revenue Market Share by Region (2018-2023)

    Table 23. Global Nivolumab Injection Revenue by Region (2024-2029) & (US$ Million)

    Table 24. Global Nivolumab Injection Revenue Market Share by Region (2024-2029)

    Table 25. North America Nivolumab Injection Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 26. North America Nivolumab Injection Sales by Country (2018-2023) & (K Units)

    Table 27. North America Nivolumab Injection Sales by Country (2024-2029) & (K Units)

    Table 28. North America Nivolumab Injection Revenue by Country (2018-2023) & (US$ Million)

    Table 29. North America Nivolumab Injection Revenue by Country (2024-2029) & (US$ Million)

    Table 30. Europe Nivolumab Injection Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 31. Europe Nivolumab Injection Sales by Country (2018-2023) & (K Units)

    Table 32. Europe Nivolumab Injection Sales by Country (2024-2029) & (K Units)

    Table 33. Europe Nivolumab Injection Revenue by Country (2018-2023) & (US$ Million)

    Table 34. Europe Nivolumab Injection Revenue by Country (2024-2029) & (US$ Million)

    Table 35. Asia Pacific Nivolumab Injection Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)

    Table 36. Asia Pacific Nivolumab Injection Sales by Region (2018-2023) & (K Units)

    Table 37. Asia Pacific Nivolumab Injection Sales by Region (2024-2029) & (K Units)

    Table 38. Asia Pacific Nivolumab Injection Revenue by Region (2018-2023) & (US$ Million)

    Table 39. Asia Pacific Nivolumab Injection Revenue by Region (2024-2029) & (US$ Million)

    Table 40. Latin America Nivolumab Injection Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 41. Latin America Nivolumab Injection Sales by Country (2018-2023) & (K Units)

    Table 42. Latin America Nivolumab Injection Sales by Country (2024-2029) & (K Units)

    Table 43. Latin America Nivolumab Injection Revenue by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Nivolumab Injection Revenue by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Nivolumab Injection Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 46. Middle East & Africa Nivolumab Injection Sales by Country (2018-2023) & (K Units)

    Table 47. Middle East & Africa Nivolumab Injection Sales by Country (2024-2029) & (K Units)

    Table 48. Middle East & Africa Nivolumab Injection Revenue by Country (2018-2023) & (US$ Million)

    Table 49. Middle East & Africa Nivolumab Injection Revenue by Country (2024-2029) & (US$ Million)

    Table 50. Global Nivolumab Injection Sales (K Units) by Type (2018-2023)

    Table 51. Global Nivolumab Injection Sales (K Units) by Type (2024-2029)

    Table 52. Global Nivolumab Injection Sales Market Share by Type (2018-2023)

    Table 53. Global Nivolumab Injection Sales Market Share by Type (2024-2029)

    Table 54. Global Nivolumab Injection Revenue (US$ Million) by Type (2018-2023)

    Table 55. Global Nivolumab Injection Revenue (US$ Million) by Type (2024-2029)

    Table 56. Global Nivolumab Injection Revenue Market Share by Type (2018-2023)

    Table 57. Global Nivolumab Injection Revenue Market Share by Type (2024-2029)

    Table 58. Global Nivolumab Injection Price (US$/Unit) by Type (2018-2023)

    Table 59. Global Nivolumab Injection Price (US$/Unit) by Type (2024-2029)

    Table 60. Global Nivolumab Injection Sales (K Units) by Application (2018-2023)

    Table 61. Global Nivolumab Injection Sales (K Units) by Application (2024-2029)

    Table 62. Global Nivolumab Injection Sales Market Share by Application (2018-2023)

    Table 63. Global Nivolumab Injection Sales Market Share by Application (2024-2029)

    Table 64. Global Nivolumab Injection Revenue (US$ Million) by Application (2018-2023)

    Table 65. Global Nivolumab Injection Revenue (US$ Million) by Application (2024-2029)

    Table 66. Global Nivolumab Injection Revenue Market Share by Application (2018-2023)

    Table 67. Global Nivolumab Injection Revenue Market Share by Application (2024-2029)

    Table 68. Global Nivolumab Injection Price (US$/Unit) by Application (2018-2023)

    Table 69. Global Nivolumab Injection Price (US$/Unit) by Application (2024-2029)

    Table 70. AbbVie Corporation Information

    Table 71. AbbVie Description and Business Overview

    Table 72. AbbVie Nivolumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 73. AbbVie Nivolumab Injection Product

    Table 74. AbbVie Recent Developments/Updates

    Table 75. Allergan Corporation Information

    Table 76. Allergan Description and Business Overview

    Table 77. Allergan Nivolumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 78. Allergan Nivolumab Injection Product

    Table 79. Allergan Recent Developments/Updates

    Table 80. Ono Pharmaceutical Corporation Information

    Table 81. Ono Pharmaceutical Description and Business Overview

    Table 82. Ono Pharmaceutical Nivolumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 83. Ono Pharmaceutical Nivolumab Injection Product

    Table 84. Ono Pharmaceutical Recent Developments/Updates

    Table 85. Sinopharm Corporation Information

    Table 86. Sinopharm Description and Business Overview

    Table 87. Sinopharm Nivolumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 88. Sinopharm Nivolumab Injection Product

    Table 89. Sinopharm Recent Developments/Updates

    Table 90. Bristol-Myers Squibb Corporation Information

    Table 91. Bristol-Myers Squibb Description and Business Overview

    Table 92. Bristol-Myers Squibb Nivolumab Injection Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 93. Bristol-Myers Squibb Nivolumab Injection Product

    Table 94. Bristol-Myers Squibb Recent Developments/Updates

    Table 95. Key Raw Materials Lists

    Table 96. Raw Materials Key Suppliers Lists

    Table 97. Nivolumab Injection Distributors List

    Table 98. Nivolumab Injection Customers List

    Table 99. Nivolumab Injection Market Trends

    Table 100. Nivolumab Injection Market Drivers

    Table 101. Nivolumab Injection Market Challenges

    Table 102. Nivolumab Injection Market Restraints

    Table 103. Research Programs/Design for This Report

    Table 104. Key Data Information from Secondary Sources

    Table 105. Key Data Information from Primary Sources

List of Figures

    Figure 1. Product Picture of Nivolumab Injection

    Figure 2. Global Nivolumab Injection Market Value Comparison by Type (2023-2029) & (US$ Million)

    Figure 3. Global Nivolumab Injection Market Share by Type in 2022 & 2029

    Figure 4. 100IU Product Picture

    Figure 5. 50IU Product Picture

    Figure 6. Other Product Picture

    Figure 7. Global Nivolumab Injection Market Value Comparison by Application (2023-2029) & (US$ Million)

    Figure 8. Global Nivolumab Injection Market Share by Application in 2022 & 2029

    Figure 9. Unresectable Melanoma

    Figure 10. Metastatic Melanoma

    Figure 11. Metastatic Squamous NSCLC

    Figure 12. Classical Hodgkin Lymphoma

    Figure 13. Renal Cell Carcinoma

    Figure 14. Other

    Figure 15. Global Nivolumab Injection Revenue, (US$ Million), 2018 VS 2022 VS 2029

    Figure 16. Global Nivolumab Injection Market Size (2018-2029) & (US$ Million)

    Figure 17. Global Nivolumab Injection Sales (2018-2029) & (K Units)

    Figure 18. Global Nivolumab Injection Average Price (US$/Unit) & (2018-2029)

    Figure 19. Nivolumab Injection Report Years Considered

    Figure 20. Nivolumab Injection Sales Share by Manufacturers in 2022

    Figure 21. Global Nivolumab Injection Revenue Share by Manufacturers in 2022

    Figure 22. The Global 5 and 10 Largest Nivolumab Injection Players: Market Share by Revenue in 2022

    Figure 23. Nivolumab Injection Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

    Figure 24. Global Nivolumab Injection Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Figure 25. North America Nivolumab Injection Sales Market Share by Country (2018-2029)

    Figure 26. North America Nivolumab Injection Revenue Market Share by Country (2018-2029)

    Figure 27. U.S. Nivolumab Injection Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 28. Canada Nivolumab Injection Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 29. Europe Nivolumab Injection Sales Market Share by Country (2018-2029)

    Figure 30. Europe Nivolumab Injection Revenue Market Share by Country (2018-2029)

    Figure 31. Germany Nivolumab Injection Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 32. France Nivolumab Injection Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 33. U.K. Nivolumab Injection Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 34. Italy Nivolumab Injection Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 35. Russia Nivolumab Injection Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 36. Asia Pacific Nivolumab Injection Sales Market Share by Region (2018-2029)

    Figure 37. Asia Pacific Nivolumab Injection Revenue Market Share by Region (2018-2029)

    Figure 38. China Nivolumab Injection Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 39. Japan Nivolumab Injection Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 40. South Korea Nivolumab Injection Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 41. India Nivolumab Injection Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 42. Australia Nivolumab Injection Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 43. Taiwan Nivolumab Injection Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 44. Indonesia Nivolumab Injection Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 45. Thailand Nivolumab Injection Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 46. Malaysia Nivolumab Injection Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 47. Philippines Nivolumab Injection Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 48. Latin America Nivolumab Injection Sales Market Share by Country (2018-2029)

    Figure 49. Latin America Nivolumab Injection Revenue Market Share by Country (2018-2029)

    Figure 50. Mexico Nivolumab Injection Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 51. Brazil Nivolumab Injection Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 52. Argentina Nivolumab Injection Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 53. Middle East & Africa Nivolumab Injection Sales Market Share by Country (2018-2029)

    Figure 54. Middle East & Africa Nivolumab Injection Revenue Market Share by Country (2018-2029)

    Figure 55. Turkey Nivolumab Injection Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 56. Saudi Arabia Nivolumab Injection Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 57. UAE Nivolumab Injection Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 58. Global Sales Market Share of Nivolumab Injection by Type (2018-2029)

    Figure 59. Global Revenue Market Share of Nivolumab Injection by Type (2018-2029)

    Figure 60. Global Nivolumab Injection Price (US$/Unit) by Type (2018-2029)

    Figure 61. Global Sales Market Share of Nivolumab Injection by Application (2018-2029)

    Figure 62. Global Revenue Market Share of Nivolumab Injection by Application (2018-2029)

    Figure 63. Global Nivolumab Injection Price (US$/Unit) by Application (2018-2029)

    Figure 64. Nivolumab Injection Value Chain

    Figure 65. Nivolumab Injection Production Process

    Figure 66. Channels of Distribution (Direct Vs Distribution)

    Figure 67. Distributors Profiles

    Figure 68. Bottom-up and Top-down Approaches for This Report

    Figure 69. Data Triangulation

    Figure 70. Key Executives Interviewed